China Health Industries Stock Working Capital
| CHHE Stock | USD 0.33 0.00 0.00% |
China Health Industries fundamentals help investors to digest information that contributes to China Health's financial success or failures. It also enables traders to predict the movement of China Pink Sheet. The fundamental analysis module provides a way to measure China Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China Health pink sheet.
China |
China Health Industries Company Working Capital Analysis
China Health's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current China Health Working Capital | 25.64 M |
Most of China Health's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China Health Industries is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
In accordance with the company's disclosures, China Health Industries has a Working Capital of 25.64 M. This is 93.98% lower than that of the Personal Products sector and significantly higher than that of the Consumer Staples industry. The working capital for all United States stocks is 98.27% higher than that of the company.
China Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Health's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of China Health could also be used in its relative valuation, which is a method of valuing China Health by comparing valuation metrics of similar companies.China Health is currently under evaluation in working capital category among its peers.
China Fundamentals
| Return On Equity | -0.0186 | |||
| Return On Asset | -0.021 | |||
| Current Valuation | (25.17 M) | |||
| Shares Outstanding | 65.54 M | |||
| Shares Owned By Insiders | 31.29 % | |||
| Price To Earning | 4.02 X | |||
| Price To Book | 0.28 X | |||
| Price To Sales | 1,000,000 X | |||
| Revenue | 267 | |||
| Gross Profit | (1.48 K) | |||
| EBITDA | 479.53 K | |||
| Net Income | (353.95 K) | |||
| Cash And Equivalents | 44.79 M | |||
| Cash Per Share | 0.68 X | |||
| Total Debt | 6.76 M | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 5.74 X | |||
| Book Value Per Share | 0.61 X | |||
| Cash Flow From Operations | 2.12 M | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 45 | |||
| Beta | -9.15 | |||
| Market Capitalization | 10.5 M | |||
| Total Asset | 50.75 M | |||
| Retained Earnings | 32.92 M | |||
| Working Capital | 25.64 M | |||
| Current Asset | 31.62 M | |||
| Current Liabilities | 5.98 M | |||
| Z Score | 0.6 | |||
| Net Asset | 50.75 M |
About China Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Health Industries's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Health Industries based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in China Pink Sheet
China Health financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Health security.